Literature DB >> 16959660

The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status.

Thomas Y Ito1, Mary Lake Polan, Beverly Whipple, Aileen Sontag Trant.   

Abstract

We conducted a double-blind, placebo-controlled study to determine the role of dietary supplementation on sexual function in women of differing menopausal status. One hundred eight (108) women, age 22-73 years, who reported a lack of sexual desire, enrolled as participants. Of these, 55 received ArginMax for women and 53 received placebo. ArginMax for women contains L-arginine, ginseng, ginkgo, damiana, multivitamins, and minerals. The 108 women, given definitions, self-reported as 59 premenopausal (PRE); 20 perimenopausal (PERI), and 29 postmenopausal (POST). After 4 weeks, PRE women on ArginMax primarily reported significant improvement in level of sexual desire (72%; p = 0.03) and satisfaction with overall sex life (68%; p = 0.007), compared with placebo group, according to the Female Sexual Function Index (FSFI; Kaplan et al., 1999) scales. Frequency of sexual desire (60%; p = 0.05) and frequency of intercourse (56% p = 0.01) also increased among the PRE women. In contrast, among PERI women, primary improvements were reported for frequency of intercourse (86%; p = 0.002), satisfaction with sexual relationship (79%; p = 0.03), and vaginal dryness (64%; p = 0.03) compared with placebo group. POST women primarily showed an increased in level of sexual desire, with 51% showing improvement, compared with only 8% in the placebo group (p = 0.008). Nutritional intervention plays an important role in women's sexual health, but issues and areas of greatest improvement differ among women of different menopausal states. The largest number of attribute improvements were seen in PRE and PERI women, although attribute types vary among these groups. Level of desire was shown to increase significantly in POST women. Since ArginMax for women has been shown to exhibit no estrogen activity, it may be desirable alternative to hormone therapy for sexual concerns.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959660     DOI: 10.1080/00926230600834901

Source DB:  PubMed          Journal:  J Sex Marital Ther        ISSN: 0092-623X


  10 in total

Review 1.  Flibanserin for hypoactive sexual desire disorder: place in therapy.

Authors:  Faina Gelman; Jessica Atrio
Journal:  Ther Adv Chronic Dis       Date:  2017-01-18       Impact factor: 5.091

Review 2.  Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment.

Authors:  Jessica A Pettigrew; Andrew M Novick
Journal:  J Midwifery Womens Health       Date:  2021-09-12       Impact factor: 2.388

3.  Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106.

Authors:  Kathryn M Greven; L Douglas Case; Lawrence R Nycum; Patricia J Zekan; David D Hurd; Ernie P Balcueva; Glenn M Mills; Robin Zon; Patrick J Flynn; David Biggs; Edward G Shaw; Glenn Lesser; Michelle J Naughton
Journal:  J Community Support Oncol       Date:  2015-03

Review 4.  Female sexual dysfunction: therapeutic options and experimental challenges.

Authors:  Kyan J Allahdadi; Rita C A Tostes; R Clinton Webb
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2009-10

5.  Sexual Health in the Elderly Population.

Authors:  John S Fisher; Andrew Rezk; Elie Nwefo; John Masterson; Ranjith Ramasamy
Journal:  Curr Sex Health Rep       Date:  2020-10-29

6.  Comparison of Elaeagnus angustifolia Extract and Sildenafil Citrate on Female Orgasmic Disorders: A Randomized Clinical Trial.

Authors:  Marzieh Akbarzadeh; Sanaz Zeinalzadeh; Jaleh Zolghadri; Abdolali Mohagheghzadeh; Pouya Faridi; Mehrab Sayadi
Journal:  J Reprod Infertil       Date:  2014-10

7.  Comparison of the effect of Elaeagnus angustifolia flower capsule and sildenafil citrate tablet female sexual interest/arousal disorder in clinical trial study.

Authors:  Sanaz Zeinalzadeh; Abdol Ali Mohagheghzadeh; Fatemeh Ahmadinezhad; Marzieh Akbarzadeh
Journal:  J Family Med Prim Care       Date:  2019-11-15

Review 8.  Ginseng: A bibliometric analysis of 40-year journey of global clinical trials.

Authors:  Weijie Chen; Peifen Yao; Chi Teng Vong; Xiuzhu Li; Zhejie Chen; Jianbo Xiao; Shengpeng Wang; Yitao Wang
Journal:  J Adv Res       Date:  2020-07-30       Impact factor: 10.479

Review 9.  A systematic review of clinical trials on Ginkgo (Ginkgo biloba) effectiveness on sexual function and its safety.

Authors:  Zahra Niazi Mashhadi; Morvarid Irani; Mahin Kiyani Mask; Clara Methie
Journal:  Avicenna J Phytomed       Date:  2021 Jul-Aug

10.  Triple-blind, placebo-controlled trial of Ginkgo biloba extract on sexual desire in postmenopausal women in Tehran.

Authors:  Mina Amiri Pebdani; Simin Taavoni; Naima Seyedfatemi; Hamid Haghani
Journal:  Iran J Nurs Midwifery Res       Date:  2014-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.